Literature DB >> 8626394

Phosphorylation of p105 PEST sequence via a redox-insensitive pathway up-regulates processing of p50 NF-kappaB.

M L MacKichan1, F Logeat, A Israël.   

Abstract

The p105 Rel protein has dual functions; it is the precursor of the p5O subunit of NF-kappaB, and it acts as an IkappaB-like inhibitor to retain other Rel subunits in the cytoplasm. We have investigated the posttranslational regulation of p105 following activation of Jurkat T cells and find that a rapid and sustained phosphorylation of p105 is induced. The inducible phosphorylation occurs on multiple serines in the C-terminal-most 150 amino acids of the molecule, a region rich in Pro, Glu, Ser, and Thr residues. Phosphorylation of p105 in Jurkat cells treated with phorbol 12-myristate 13-acetate/ionomycin or with okadaic acid, another activator of NF-kappaB, is correlated with an increase in proteolytic processing to p5O. Intact PEST sequences are required for the phorbol 12-myristate 13-acetate/ionomycin-induced p105 processing, as a 68-amino acid C-terminal deletion abolishes the response to stimulation. When compounds that block Ikappa B alpha phosphorylation and degradation were tested, the serine protease inhibitors L-1-tosylamido-2-phenylethyl chloromethyl ketone and 1-chloro-3-tosyl-amido-7-amino-2-heptanone blocked inducible p105 phosphorylation, but the antioxidants pyrrolidine dithiocarbamate and butylated hydroxyanisol did not. Thus, while regulation of the p105 IkappaB resembles that of lkappaBa, involving inducible serine phosphorylation and proteolysis of the inhibitory ankyrin repeat domain, it depends on a different, redox-insensitive, signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626394     DOI: 10.1074/jbc.271.11.6084

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  SCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinase.

Authors:  A Orian; H Gonen; B Bercovich; I Fajerman; E Eytan; A Israël; F Mercurio; K Iwai; A L Schwartz; A Ciechanover
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

Review 2.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

3.  Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1.

Authors:  Mark Y Chiang; Mina L Xu; Gavin Histen; Olga Shestova; Monideepa Roy; Yunsun Nam; Stephen C Blacklow; David B Sacks; Warren S Pear; Jon C Aster
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

4.  betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932.

Authors:  Valerie Lang; Julia Janzen; Gregory Zvi Fischer; Yasmina Soneji; Sören Beinke; Andres Salmeron; Hamish Allen; Ronald T Hay; Yinon Ben-Neriah; Steven C Ley
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

5.  Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.

Authors:  V Heissmeyer; D Krappmann; E N Hatada; C Scheidereit
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

6.  Structural motifs involved in ubiquitin-mediated processing of the NF-kappaB precursor p105: roles of the glycine-rich region and a downstream ubiquitination domain.

Authors:  A Orian; A L Schwartz; A Israël; S Whiteside; C Kahana; A Ciechanover
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

7.  The role of constitutive NF-kappaB activity in PC-3 human prostate cancer cell invasive behavior.

Authors:  P F Lindholm; J Bub; S Kaul; V B Shidham; A Kajdacsy-Balla
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

8.  Cotranslational dimerization of the Rel homology domain of NF-kappaB1 generates p50-p105 heterodimers and is required for effective p50 production.

Authors:  L Lin; G N DeMartino; W C Greene
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

9.  Deletion analysis of BMI1 oncoprotein identifies its negative regulatory domain.

Authors:  Ajay K Yadav; Anagh A Sahasrabuddhe; Manjari Dimri; Prashant V Bommi; Rachana Sainger; Goberdhan P Dimri
Journal:  Mol Cancer       Date:  2010-06-22       Impact factor: 27.401

10.  Dual effects of IkappaB kinase beta-mediated phosphorylation on p105 Fate: SCF(beta-TrCP)-dependent degradation and SCF(beta-TrCP)-independent processing.

Authors:  Shai Cohen; Hillit Achbert-Weiner; Aaron Ciechanover
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.